Page last updated: 2024-10-30

mecamylamine and Dyskinesia, Drug-Induced

mecamylamine has been researched along with Dyskinesia, Drug-Induced in 2 studies

Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Iha, HA1
Kunisawa, N1
Shimizu, S1
Onishi, M1
Nomura, Y1
Matsubara, N1
Iwai, C1
Ogawa, M1
Hashimura, M1
Sato, K1
Kato, M1
Ohno, Y1
Bordia, T1
Campos, C1
McIntosh, JM1
Quik, M1

Other Studies

2 other studies available for mecamylamine and Dyskinesia, Drug-Induced

ArticleYear
Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor.
    Neurotoxicity research, 2019, Volume: 35, Issue:3

    Topics: Animals; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gene Expression; Male; M

2019
Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 333, Issue:3

    Topics: Amphetamine; Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Bridged Bicyclo Compo

2010